Zydus receives final US FDA approval for Brivaracetam tablets
Brivaracetam is indicated for the treatment of partial-onset seizures in patients four years of age and older
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.